Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Farzan Nima Create: Alert

All | News | Filings
Date FiledTypeDescription
06/08/2023 4 Farzan Nima (Director) has filed a Form 4 on Keros Therapeutics, Inc.
Txns: Granted 10,000 options to buy @ $48.79, valued at $487.9k
02/14/2023 4 Farzan Nima (CEO) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Granted 750,000 options to buy @ $6.78, valued at $5.1M
06/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/15/2022 4 Farzan Nima (CEO) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Granted 400,000 options to buy @ $10.03, valued at $4M
06/03/2021 4 Farzan Nima (Director) has filed a Form 4 on Keros Therapeutics, Inc.
Txns: Granted 8,293 options to buy @ $51.48, valued at $426.9k
02/16/2021 4 Farzan Nima (CEO) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Granted 275,000 options to buy @ $35.38, valued at $9.7M
12/02/2020 3 Farzan Nima (President and CEO) has filed a Form 3 on Kinnate Biopharma Inc.
05/29/2020 4 Farzan Nima (Director) has filed a Form 4 on Keros Therapeutics, Inc.
Txns: Granted 8,500 options to buy @ $28.74, valued at $244.3k
04/07/2020 3 Farzan Nima (Director) has filed a Form 3 on Keros Therapeutics, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy